Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

News & Analysis

China biotech company and industry news and analysis...

Novadip's $22 Million B Round for Skeletal Tissue Therapies Includes HK Investor

Innovent and NeoCura to Test PD-1/mRNA Vaccine Combination for Cancer

Fosun Announces $628 Million Deal for Majority Stake in Chengdu Antejin

CANbridge Doses First Patient in Phase II GBM Trial

SciNeuro Partners with Mabylon to Discover Antibodies for Neurological Diseases

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China